How we're saving sight

Clinical and laboratory breakthroughs Discover our research

Centres and institutes_

Save Sight Institute

Preserving and restoring vision lost to all eye diseases

We're home to Australia’s leading ophthalmologists, researchers and scientists. We conduct research and clinical trials, treat patients in our clinic and educate the next generation of eye specialists.

We're finding new ways to preserve and restore vision lost to all eye diseases, including glaucoma, macular degeneration, retinal dystrophies, uveitis and inflammatory conditions. We have already saved the sight of many people living with eye disease.

We have an involved patient community, who we work with closely to raise awareness and funds for eye research. Known as SightFighters, these committed supporters are an integral part in our mission to cure blindness and vision loss.

The Save Sight Institute is based at the Sydney Eye Hospital.

Study area_

Study with us

The Specialty of Clinical Ophthalmology and Eye Health at the Save Sight Institute offers a range of courses to advance your clinical or research career in ocular health. With our focus on world-class teaching, our internationally renowned academics are educating future leaders in ophthalmology.

Research_

Clinical trials

Browse a list of current, upcoming and previous clinical trials by condition conducted by research groups across the institute.

Research_

Save Sight Institute

Phone

02 9382 7300

Expression of interest

Submit this form to enquire about higher degree research opportunities.

Save Sight Institute

Connect with us

Save Sight Institute on social media

Our news

News_

16 December 2021

World-first consortium to fight global corneal blindness

In a world first, Australian leaders in corneal bioengineering have collaborated to form BIENCO, a consortium that will develop bioengineered eye tissue to treat corneal blindness.

News_

08 October 2021

Gene therapy saves the sight of Australians with eye disease

Two teenage siblings with a rare disease have had their vision loss halted and their eye sight improved, after surgery using the world's first approved gene replacement therapy for any inherited blinding eye condition.

We acknowledge the traditional custodians of the country on which the University of Sydney campuses stand and our responsibility to respect and care for country, people and spirit.